These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 34522585)

  • 21. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembled Nucleic Acid Nanostructures for Cancer Theranostic Medicines.
    Fu J; Stankeviciute G; Oh SW; Collins J; Zhong Y; Zhang T
    Curr Top Med Chem; 2017; 17(16):1815-1828. PubMed ID: 27875979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics.
    Mao Y; Liu X
    Front Chem; 2020; 8():257. PubMed ID: 32328480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy.
    Zhou H; Qin F; Chen C
    Adv Healthc Mater; 2021 Mar; 10(5):e2001277. PubMed ID: 32985141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
    Yang B; Chen Y; Shi J
    Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breaking the Depth Dependence by Nanotechnology-Enhanced X-Ray-Excited Deep Cancer Theranostics.
    Fan W; Tang W; Lau J; Shen Z; Xie J; Shi J; Chen X
    Adv Mater; 2019 Mar; 31(12):e1806381. PubMed ID: 30698854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
    Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
    J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graphene-based nanocomposites: synthesis and their theranostic applications.
    Madni A; Noreen S; Maqbool I; Rehman F; Batool A; Kashif PM; Rehman M; Tahir N; Khan MI
    J Drug Target; 2018 Dec; 26(10):858-883. PubMed ID: 29424250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.
    Yun WS; Kim J; Lim DK; Kim DH; Jeon SI; Kim K
    Nanomaterials (Basel); 2023 Jul; 13(15):. PubMed ID: 37570543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.